scholarly journals A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancer

Lung Cancer ◽  
2013 ◽  
Vol 82 (2) ◽  
pp. 276-281 ◽  
Author(s):  
T. Ciuleanu ◽  
C.-M. Tsai ◽  
C.-J. Tsao ◽  
J. Milanowski ◽  
D. Amoroso ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Treatment

A phase II study of erlotinib as first-line treatment of advanced non-small cell lung cancer

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 7073-7073 ◽  
Author(s):  
G. Giaccone ◽  
T. Lechevalier ◽  
N. Thatcher ◽  
E. Smit ◽  
M. Janmaat ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Treatment

First line treatment of advanced non-small cell lung cancer with doxetaxel and cis-platin: A multicenter phase II study

1997 ◽  
Vol 33 ◽  
pp. S236 ◽  
Author(s):  
N. Androulakis ◽  
C. Kourousis ◽  
S. Kakolyris ◽  
A.M. Dimopoulos ◽  
E. Papadakis ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Small Cell ◽  
Line Treatment ◽  
Small Cell Lung ◽  
First Line ◽  
Multicenter Phase ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document